These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21397161)

  • 21. Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).
    Costantini E; Lazzeri M; Pistolesi D; Del Zingaro M; Frumenzio E; Boni A; Pietropaolo A; Fragalà E; Porena M
    Urol Int; 2013; 91(1):81-8. PubMed ID: 23485915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress.
    Boucher WS; Letourneau R; Huang M; Kempuraj D; Green M; Sant GR; Theoharides TC
    J Urol; 2002 Jan; 167(1):380-4. PubMed ID: 11743360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravesical instillation of resiniferatoxin for the patients with interstitial cystitis].
    Takahashi S; Yanase M; Inoue R; Ichihara K; Masumori N; Tsukamoto T; Igawa Y; Nishizawa O
    Hinyokika Kiyo; 2006 Dec; 52(12):911-3. PubMed ID: 17252971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history.
    Seth A; Teichman JM
    J Urol; 2008 Nov; 180(5):2029-33. PubMed ID: 18804240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.
    Lv YS; Zhou HL; Mao HP; Gao R; Wang YD; Xue XY
    Int Urogynecol J; 2012 Dec; 23(12):1715-20. PubMed ID: 22576327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.
    Nickel JC; Shoskes D; Irvine-Bird K
    J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronic acid-chondroitin sulfate: a potential factor to select pure stress urinary incontinence in patients with interstitial cystitis⁄painful bladder syndrome and mixed incontinence symptoms.
    Morelli M; Mocciaro R; Venturella R; Albano A; Sacchinelli A; Zullo F
    Minerva Ginecol; 2015 Apr; 67(2):121-5. PubMed ID: 25763801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.
    Payne CK; Mosbaugh PG; Forrest JB; Evans RJ; Whitmore KE; Antoci JP; Perez-Marrero R; Jacoby K; Diokno AC; O'Reilly KJ; Griebling TL; Vasavada SP; Yu AS; Frumkin LR;
    J Urol; 2005 May; 173(5):1590-4. PubMed ID: 15821499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate.
    Miodosky M; Abdul-Hai A; Tsirigotis P; Or R; Bitan M; Resnick IB; Gesundheit B; Zilberman I; Ioffe L; Leubovic A; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Oct; 38(7):507-11. PubMed ID: 16921402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
    Peng CH; Kuo HC
    Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome.
    Nickel JC; Egerdie RB; Steinhoff G; Palmer B; Hanno P
    Urology; 2010 Oct; 76(4):804-9. PubMed ID: 20494413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek--an oral multi-agent natural supplement.
    Theoharides TC; Kempuraj D; Vakali S; Sant GR
    Can J Urol; 2008 Dec; 15(6):4410-4. PubMed ID: 19046494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome.
    Riedl CR; Engelhardt PF; Daha KL; Morakis N; Pflüger H
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 May; 19(5):717-21. PubMed ID: 18097627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study.
    Constantinides C; Manousakas T; Nikolopoulos P; Stanitsas A; Haritopoulos K; Giannopoulos A
    BJU Int; 2004 Jun; 93(9):1262-6. PubMed ID: 15180619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.
    Nickel JC; Tripp DA; Pontari M; Moldwin R; Mayer R; Carr LK; Doggweiler R; Yang CC; Mishra N; Nordling J
    J Urol; 2010 Oct; 184(4):1358-63. PubMed ID: 20719340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device.
    Nickel JC; Jain P; Shore N; Anderson J; Giesing D; Lee H; Kim G; Daniel K; White S; Larrivee-Elkins C; Lekstrom-Himes J; Cima M
    Sci Transl Med; 2012 Jul; 4(143):143ra100. PubMed ID: 22814850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.
    Giannantoni A; Costantini E; Di Stasi SM; Tascini MC; Bini V; Porena M
    Eur Urol; 2006 Apr; 49(4):704-9. PubMed ID: 16417964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model.
    Sahiner IF; Soylu H; Ates E; Acar N; Ustunel I; Danisman A
    Int Braz J Urol; 2018; 44(5):1014-1022. PubMed ID: 30044599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased urinary hyaluronic acid and interstitial cystitis.
    Erickson DR; Sheykhnazari M; Ordille S; Bhavanandan VP
    J Urol; 1998 Oct; 160(4):1282-4. PubMed ID: 9751336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid.
    Porru D; Campus G; Tudino D; Valdes E; Vespa A; Scarpa RM; Usai E
    Urol Int; 1997; 59(1):26-9. PubMed ID: 9313320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.